These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15274198

  • 1. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
    Lee JJ, Kook H, Park MS, Nam JH, Choi BH, Song WH, Park KS, Lee IK, Chung IJ, Hwang TJ, Kim HJ.
    J Clin Apher; 2004; 19(2):66-70. PubMed ID: 15274198
    [Abstract] [Full Text] [Related]

  • 2. Induction of leukemic-cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens.
    Lee JJ, Park MS, Park JS, Kang HK, Kim SK, Nguyen Pham TN, Zhu XW, Cho D, Nam JH, Kim YJ, Rhee JH, Chung IJ, Kim HJ.
    J Clin Apher; 2006 Oct; 21(3):188-94. PubMed ID: 16570260
    [Abstract] [Full Text] [Related]

  • 3. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH, Kang HK, Park JS, Kim SK, Pham TN, Zhu XW, Cho D, Nam JH, Chung IJ, Kim YJ, Rhee JH, Kim HJ, Lee JJ.
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [Abstract] [Full Text] [Related]

  • 4. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C, Liepert A, Dreyig J, Kremser A, Kroell T, Freudenreich M, Schmid C, Schweiger C, Tischer J, Kolb HJ, Schmetzer H.
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
    Li L, Giannopoulos K, Reinhardt P, Tabarkiewicz J, Schmitt A, Greiner J, Rolinski J, Hus I, Dmoszynska A, Wiesneth M, Schmitt M.
    Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.
    Suminoe A, Matsuzaki A, Hattori H, Koga Y, Hara T.
    Pediatr Transplant; 2009 Sep; 13(6):746-53. PubMed ID: 19067917
    [Abstract] [Full Text] [Related]

  • 7. [T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission].
    He X, You S, Bian S.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):629-32. PubMed ID: 16200709
    [Abstract] [Full Text] [Related]

  • 8. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
    Encabo A, Solves P, Carbonell-Uberos F, Miñana MD.
    Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
    [Abstract] [Full Text] [Related]

  • 9. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
    Köhler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B, Schaekel U, Ehninger G, Bornhäuser M.
    Stem Cells; 2000 Feb; 18(2):139-47. PubMed ID: 10742386
    [Abstract] [Full Text] [Related]

  • 10. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta.
    Reich K, Hugo S, Middel P, Blaschke V, Heine A, Neumann C.
    Exp Dermatol; 2004 Dec; 13(12):740-7. PubMed ID: 15560757
    [Abstract] [Full Text] [Related]

  • 11. Generation of cytotoxic donor CD8+ T cells against relapsing leukemic cells following allogeneic transplantation by stimulation with leukemic cell- or leukemic lysate pulsed donor cell-derived dendritic cells.
    Lee JJ, Nam CE, Nam JH, Lee HC, Chung IJ, Park MS, Choi BH, Song WH, Lee IK, Park KS, Kook H, Hwang TJ, Takei M, Takaue Y, Kim HJ.
    Leuk Res; 2004 May; 28(5):517-24. PubMed ID: 15068905
    [Abstract] [Full Text] [Related]

  • 12. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
    Royer PJ, Bougras G, Ebstein F, Leveque L, Tanguy-Royer S, Simon T, Juge-Morineau N, Chevallier P, Harousseau JL, Gregoire M.
    Exp Hematol; 2008 Mar; 36(3):329-39. PubMed ID: 18207305
    [Abstract] [Full Text] [Related]

  • 13. Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia.
    Serrano-López J, Sanchez-Garcia J, Serrano J, Alvarez-Rivas MA, Garcia-Castellano JM, Roman-Gomez J, de la Rosa O, Herrera-Arroyo C, Torres-Gomez A.
    Transfusion; 2011 Jul; 51(7):1546-55. PubMed ID: 21303373
    [Abstract] [Full Text] [Related]

  • 14. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
    Liepert A, Grabrucker C, Kremser A, Dreyssig J, Ansprenger C, Freudenreich M, Kroell T, Reibke R, Tischer J, Schweiger C, Schmid C, Kolb HJ, Schmetzer H.
    Cell Immunol; 2010 Jul; 265(1):23-30. PubMed ID: 20663492
    [Abstract] [Full Text] [Related]

  • 15. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M.
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [Abstract] [Full Text] [Related]

  • 16. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A, Van de Velde AL, Nijs G, Braeckman T, Stein B, De Vries JM, Berneman ZN, Van Tendeloo VF.
    Cytotherapy; 2009 May; 11(5):653-68. PubMed ID: 19530029
    [Abstract] [Full Text] [Related]

  • 17. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
    Lee JJ, Choi BH, Kang HK, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ.
    Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
    [Abstract] [Full Text] [Related]

  • 18. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC, Nijhuis LE, de Jong EC, te Velde AA, Pajkrt D, Reesink HW, Beld MG, van Deventer SJ, Jansen PL.
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [Abstract] [Full Text] [Related]

  • 19. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
    Draube A, Beyer M, Wolf J.
    Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
    [Abstract] [Full Text] [Related]

  • 20. Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.
    Schmitt A, Reinhardt P, Hus I, Tabarkiewicz J, Roliñski J, Barth T, Giannopoulos K, Dmoszyñska A, Wiesneth M, Schmitt M.
    Transfusion; 2007 Sep; 47(9):1588-94. PubMed ID: 17725721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.